Title |
Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies
|
---|---|
Published in |
International Journal of Bipolar Disorders, July 2013
|
DOI | 10.1186/2194-7511-1-10 |
Pubmed ID | |
Authors |
Allan H Young, Joseph R Calabrese, Urban Gustafsson, Michael Berk, Susan L McElroy, Michael E Thase, Trisha Suppes, Willie Earley |
Abstract |
Despite being present in up to 1% of the population, few controlled trials have examined the efficacy of treatments for bipolar II depression. Pooled data are presented from four placebo-controlled studies (BOLDER I [5077US/0049] and II [D1447C00135]; EMBOLDEN I [D1447C00001] and II [D1447C00134]) that evaluated the efficacy of quetiapine monotherapy for depressive episodes in patients with bipolar II disorder. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 50 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 8 | 16% |
Student > Ph. D. Student | 6 | 12% |
Other | 5 | 10% |
Researcher | 5 | 10% |
Professor > Associate Professor | 4 | 8% |
Other | 12 | 24% |
Unknown | 11 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 39% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 10% |
Psychology | 3 | 6% |
Social Sciences | 3 | 6% |
Nursing and Health Professions | 2 | 4% |
Other | 4 | 8% |
Unknown | 14 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2013.
All research outputs
#17,690,900
of 22,713,403 outputs
Outputs from International Journal of Bipolar Disorders
#216
of 282 outputs
Outputs of similar age
#139,630
of 194,350 outputs
Outputs of similar age from International Journal of Bipolar Disorders
#4
of 6 outputs
Altmetric has tracked 22,713,403 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 282 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,350 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.